Dr. Brian Nicholson

Dr. Brian Nicholson
Dr. Nicholson was born in Miami, Florida just prior to his father’s medical school graduation. While his father was serving in the Navy, he moved around the country and spent his formative years in San Diego, California. He completed a Bachelor of Science degree in Biological Sciences at the University of California, Davis before entering The Chicago Medical School. After finishing a 6-year Urology residency at Loyola University Medical Center outside of Chicago, he was accepted as a Fellow in Urologic Oncology at the University of Virginia in Charlottesville, Virginia. He spent four years there as a Fellow and junior faculty member. Dr. Nicholson then transitioned from academic medicine to Lubbock, Texas in 2004 where he partnered with Dr. James Kirk and Dr. Rex Reynolds to form Kirk, Nicholson and Reynolds Urology, LLP. He was honored when his father, Dr. Thomas Nicholson joined the partnership a few years later. Dr. Nicholson has received numerous awards during his training and career showcasing his dedication to the field of Urology and Urologic Oncology. He has authored or contributed to several peer-reviewed articles and book chapters. In 2012 and again in 2018, he was one of six distinguished physicians to earn a Physician of Excellence Award, which is selected by his peers within the Covenant Health System. Married in 1997, he and his wife Alison are proud parents of 5 children. Dr. Nicholson plans to continue to provide award-winning service to the West Texas and Eastern New Mexico area for years to come.
Medical School:

The Chicago Medical School

Residency:

Loyola University Medical Center

Fellowship:

University of Virginia, Charlottesville, Virginia

Undergraduate:

University of California, Davis

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only